Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04612660 · ClinicalTrials.gov registry record · NA
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT04612660 is a NA study that has completed, run by Temple University. The registered enrollment target is 156 participants.
The verdict
NCT04612660, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
The study was to pilot test the feability of using HPV self-sampling testing to increase cervical cancer screening among under-served Asian women through engaging community-based organizations in the greater Philadelphia and New York City area, addressing a significant global cancer burden, the preventable infection-related cervical cancer.
Interventions
- BEHAVIORAL Patient Navigation
- BEHAVIORAL General Health Education
- BEHAVIORAL Education on cervical cancer prevetnion
- BEHAVIORAL Dynamic group interaction
- BEHAVIORAL Physician engagement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04612660
The ClinicalTrials.gov registry entry for NCT04612660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Patient Navigation is the first listed.
NCT04612660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04612660 about?
NCT04612660 is a clinical study titled "HPV Self-test to Increase Cervical Cancer Screening in Asian Women". The study was to pilot test the feability of using HPV self-sampling testing to increase cervical cancer screening among under-served Asian women through engaging community-based organizations in the greater Philadelphia and New York City area, addressing a significant global cancer burden, the prev...
What is the current status of trial NCT04612660?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2014-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT04612660?
The interventions under investigation include: Patient Navigation (BEHAVIORAL), General Health Education (BEHAVIORAL), Education on cervical cancer prevetnion (BEHAVIORAL), Dynamic group interaction (BEHAVIORAL), Physician engagement (BEHAVIORAL).
Who is sponsoring clinical trial NCT04612660?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.